Teladoc Historical Cash Flow
| TDOC Stock | USD 11.18 0.21 1.84% |
Analysis of Teladoc cash flow over time is an excellent tool to project Teladoc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 11 M or Begin Period Cash Flow of 1.1 B as it is a great indicator of Teladoc ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Teladoc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Teladoc is a good buy for the upcoming year.
Teladoc |
About Teladoc Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Teladoc balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Teladoc's non-liquid assets can be easily converted into cash.
Teladoc Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Teladoc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Teladoc operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Teladoc's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Teladoc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.At present, Teladoc's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 233.9 M, whereas Sale Purchase Of Stock is projected to grow to (237.7 K).
| 2022 | 2023 | 2024 | 2025 (projected) | Other Non Cash Items | 13.4B | 7.8M | 8.9M | 8.5M | Depreciation | 270.6M | 351.3M | 404.0M | 424.2M |
Teladoc cash flow statement Correlations
Click cells to compare fundamentals
Teladoc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Teladoc cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | (26.7M) | 42.6M | 12.4M | (278K) | (250.2K) | (237.7K) | |
| Change To Inventory | (24.7M) | (19.5M) | 14.8M | 24.1M | 27.7M | 29.1M | |
| Change In Cash | 219.0M | 160.2M | 24.7M | 205.5M | 236.3M | 248.1M | |
| Stock Based Compensation | 475.5M | 302.6M | 217.9M | 201.6M | 231.8M | 135.0M | |
| Free Cash Flow | (79.6M) | 130.1M | 16.5M | 193.7M | 222.7M | 233.9M | |
| Change In Working Capital | (90.5M) | (50.3M) | (61.0M) | 11.6M | 10.5M | 11.0M | |
| Begin Period Cash Flow | 514.4M | 733.3M | 893.5M | 918.2M | 1.1B | 1.1B | |
| Other Cashflows From Financing Activities | 97.3M | 40.9M | 6.5M | 10.9M | 9.8M | 9.3M | |
| Depreciation | 78.1M | 219.6M | 270.6M | 351.3M | 404.0M | 424.2M | |
| Other Non Cash Items | 58.6M | 109.1M | 13.4B | 7.8M | 8.9M | 8.5M | |
| Capital Expenditures | 26.0M | 63.9M | 172.8M | 156.3M | 179.8M | 188.8M | |
| Total Cash From Operating Activities | (53.5M) | 194.0M | 189.3M | 350.0M | 402.5M | 422.7M | |
| Change To Account Receivables | (21.1M) | (17.5M) | (61.6M) | (10.3M) | (9.2M) | (9.7M) | |
| Net Income | (485.1M) | (428.8M) | (13.7B) | (220.4M) | (198.3M) | (208.2M) | |
| Total Cash From Financing Activities | 859.1M | 40.9M | 6.5M | 10.9M | 12.5M | 11.9M | |
| End Period Cash Flow | 733.3M | 893.5M | 918.2M | 1.1B | 1.3B | 1.4B | |
| Investments | 2.5M | 60.9M | 2.5M | (173.7M) | (156.4M) | (148.5M) | |
| Net Borrowings | 850.9M | 965.9M | (914K) | (3.1M) | (3.6M) | (3.4M) | |
| Total Cashflows From Investing Activities | 25.0M | (591.0M) | (73.0M) | (167.7M) | (151.0M) | (158.5M) | |
| Change To Operating Activities | 14.8M | 25.6M | (35.1M) | (31.2M) | (28.1M) | (26.7M) | |
| Other Cashflows From Investing Activities | (26.0M) | (55.2M) | 2.5M | 1K | 1.2K | 1.2K | |
| Change To Netincome | 58.5M | 399.7M | 453.5M | 13.6B | 15.7B | 16.5B | |
| Change To Liabilities | 6.1M | (37.8M) | 21.7M | 5.0M | 4.5M | 4.7M | |
| Change Receivables | (15.9M) | (21.1M) | (17.5M) | (61.6M) | (55.5M) | (52.7M) | |
| Cash And Cash Equivalents Changes | 90.0M | 214.7M | 162.0M | 28.0M | 32.3M | 30.6M | |
| Cash Flows Other Operating | 80.0M | 46.0M | 84.3M | (1.2M) | (1.4M) | (1.3M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.78) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.